News
Fidelis Insurance Holdings Limited (NYSE:FIHL) Q3 2023 Earnings Call Transcript November 21, 2023 8:00 AM ET Company Participants Jillian Benson – Group Head of...
Hi, what are you looking for?
iFintechWorld
iFintechWorld
News
This article was written by Follow Author and entrepreneur. My articles typically cover macroeconomic trends, portfolio strategy, value investing, and behavioral finance. I like...
News
This article was written by Follow Dhierin-Perkash Bechai is an aerospace, defense and airline analyst. Dhierin runs the investing group The Aerospace Forum, whose...
News
This article was written by Follow Yiannis Zourmpanos, founder of Yiazou IQ, an AI-driven stock research platform providing all-in-one stock reports. Experience: Previously worked...
News
As everyone knows, Monster Beverage (NASDAQ:MNST) has been a stock that has given spectacular returns to its shareholders so far for decades. It has...
News
If you’re like me, you rarely transact in cash anymore. I can probably count on one hand how many times I use physical cash...
News
Elevator Pitch I stick with my Hold rating for Cushman & Wakefield plc (NYSE:CWK) shares. With my previous article for CWK published on September...
News
Currently I am covering the biggest airplane manufacturers in the world. I am also covering various airlines and lessors that are the customers for...
News
BiomX logo (BiomX website) BiomX Inc. (NYSE:PHGE) is a clinical-stage biotech company that develops bacteriophage (“phage”) cocktails to treat various diseases utilizing its next-generation...
News
Back in March, I placed a “Sell” rating on Beyond Meat (NASDAQ:BYND), saying management greatly misread demand for its product. I reiterated my “Sell”...
News
I have to confess that between my husband and me, we are not very “street smart” when it comes to raising teenagers. I’m embarrassed...
News
X Financial (NYSE:XYF) Q3 2023 Results Conference Call November 22, 2023 9:00 PM ET Company Participants Victoria Yu – Investor Relations Kan Li –...
News
Investment Thesis In my opinion, Bristol-Myers Squibb (NYSE:BMY) stands at a critical juncture. My forthcoming analysis contends that the company’s valuation and future market...
